Elanco Animal Health Inc (ELAN)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SERVICES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Jeffrey N. Simmons
Employees:
5,590
2500 INNOVATION WAY, GREENFIELD, IN 46140
877-352-6261

Elanco Animal Health Incorporated, an animal health company, develops, manufactures, and markets products for companion and food animals. The company offers companion animal disease prevention products, such as parasiticide products that protect pets from worms, fleas, and ticks; companion animal therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications; vaccines, nutritional enzymes, and animal-only antibiotics; and a range of food animal products used in ruminant and swine production. It sells its products to third-party distributors; veterinarians; and food animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations in approximately 90 countries in North America, Europe, the Middle East, Africa, Latin America, and the Asia-Pacific. Elanco Animal Health Incorporated has a research and development collaboration with AgBiome, Inc. to develop nutritional health products for swine. The company was founded in 1954 and is headquartered in Greenfield, Indiana.

Data derived from most recent annual or quarterly report
Market Cap 9.752 Billion Shares Outstanding473.187 Million Avg 30-day Volume 4.749 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-0.55
Price to Revenue2.7046 Debt to Equity0.8058 EBITDA503 Million
Price to Book Value1.687 Operating Margin-3.6858000000000004 Enterprise Value18.633 Billion
Current Ratio2.444 EPS Growth0.409 Quick Ratio1.174
1 Yr BETA 0.8808 52-week High/Low 37.49 / 19.56 Profit Margin-7.6453
Operating Cash Flow Growth1834.7826 Altman Z-Score1.2074 Free Cash Flow to Firm 126.5 Million
View SEC Filings from ELAN instead.

View recent insider trading info

Funds Holding ELAN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ELAN BETA

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2022-05-19:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-05-09:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-04-20:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-04-13:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 7.01: Regulation FD Disclosure
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-03-29:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-02-24:
    Item 2.02: Results of Operations and Financial Condition
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-01-14:
    Item 8.01: Other Events
  • 8-K: filed on 2022-01-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-01-06:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2021-11-30:
    Item 2.05: Cost Associated with Exit or Disposal Activities
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    20 Thousand total shares from 2 transactions

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    HOOVER R DAVID

    21,676 2022-05-31 15

    BILBREY JOHN P

    10,227 2022-05-31 13

    KURZIUS LAWRENCE ERIK

    10,793 2022-05-31 12

    MODI RAJEEV A. SEE REMARKS

    34,457 2022-04-01 2

    SIMMONS JEFFREY N PRESIDENT, CEO AND DIRECTOR

    752,986 2022-03-05 5

    YOUNG TODD S. SEE REMARKS

    306,655 2022-03-01 2

    CABRAL RAMIRO MARTIN SEE REMARKS

    200,880 2022-03-01 3

    KINARD DAVID S SEE REMARKS

    213,186 2022-03-01 3

    URBANEK DAVID ALAN SEE REMARKS

    213,157 2022-03-01 3

    CORREIA DE SIMAS JOSE MANUEL SEE REMARKS

    35,393 2022-03-01 2

    KIRBERGER MARCELA A. SEE REMARKS

    47,278 2022-03-01 2

    DE BRABANDER ELLEN SEE REMARKS

    98,653 2022-03-01 3

    ANAND KAPILA K

    • Director
    1,458 2021-12-31 5

    GARCIA ART A

    • Director
    23,772 2021-11-30 1

    DOYLE WILLIAM F

    • Director
    7,307 2021-11-30 1

    SCOTS-KNIGHT DENISE

    • Director
    21,208 2021-11-30 1

    HERENDEEN PAUL

    • Director
    7,307 2021-11-30 1

    KOCHEVAR DEBORAH TURNER

    • Director
    22,208 2021-11-30 1

    MCDONALD KIRK P

    • Director
    21,208 2021-11-30 1

    HARRINGTON MICHAEL J

    • Director
    35,471 2021-11-30 2

    LEE JOYCE J. EX VP PRS US PET HLTH COM OP

    • Officer
    34,628 2021-11-30 1

    FERGUSON SCOTT D.

    SACHEM HEAD CAPITAL MANAGEMENT LP

    UNCAS GP LLC

    SACHEM HEAD GP LLC

    • Director
    7,307 2021-11-30 1

    EHLE DIRK EX VP & PRES ELANCO EUROPE

    • Officer
    11,241 2021-11-30 1

    SCHACHT AARON L EXECUTIVE VICE PRESIDENT

    • Officer
    78,747 2021-10-20 1

    MASON RACQUEL HARRIS SEE REMARKS

    • Officer
    23,770 2021-07-01 1

    MEER JAMES M CHIEF ACCOUNTING OFFICER

    • Officer
    11,067 2021-06-03 0

    HICKS MICHAEL-BRYANT SEE REMARKS

    • Officer
    55,588 2021-03-01 0

    BAYER AKTIENGESELLSCHAFT

    BAYER WORLD INVESTMENTS B.V.

    • 10% Owner
    No longer subject to file 2020-12-03 0

    LIN SARENA S SEE REMARKS

    • Officer
    66,051 2020-03-01 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    HOOVER R DAVID

    2022-06-02 19:54:00 -0400 2022-05-31 A 450 $23.70 a 21,676 direct

    BILBREY JOHN P

    2022-06-02 19:53:25 -0400 2022-05-31 A 373 $23.70 a 10,227 direct

    KURZIUS LAWRENCE ERIK

    2022-06-02 19:52:32 -0400 2022-05-31 A 387 $23.70 a 10,793 direct

    HOOVER R DAVID revocable trust

    2022-05-24 16:33:40 -0400 2022-05-20 P 10,000 $23.33 a 125,000 indirect 1.6717 6.4724 6.4724 6 0.0 1

    BILBREY JOHN P revocable trust

    2022-05-13 17:59:38 -0400 2022-05-11 P 10,000 $22.03 a 34,222 indirect 3.8181 1.6302 4.1184 5 -0.3003 4

    BILBREY JOHN P

    2022-05-03 17:30:08 -0400 2022-04-29 A 349 $25.31 a 9,854 direct

    HOOVER R DAVID

    2022-05-03 17:34:20 -0400 2022-04-29 A 421 $25.31 a 21,226 direct

    KURZIUS LAWRENCE ERIK

    2022-05-03 17:31:53 -0400 2022-04-29 A 362 $25.31 a 10,406 direct

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    ELANCO ANIMAL HEALTH INC ELAN 2022-06-24 22:15:03 UTC 1.32 0.25 9100000
    ELANCO ANIMAL HEALTH INC ELAN 2022-06-24 21:45:03 UTC 1.32 0.25 9100000
    ELANCO ANIMAL HEALTH INC ELAN 2022-06-24 21:15:04 UTC 1.32 0.25 9000000
    ELANCO ANIMAL HEALTH INC ELAN 2022-06-24 20:45:03 UTC 1.32 0.25 9000000
    ELANCO ANIMAL HEALTH INC ELAN 2022-06-24 20:15:03 UTC 1.32 0.25 9000000
    ELANCO ANIMAL HEALTH INC ELAN 2022-06-24 19:45:03 UTC 1.32 0.25 9000000
    ELANCO ANIMAL HEALTH INC ELAN 2022-06-24 19:15:03 UTC 1.32 0.25 9000000
    ELANCO ANIMAL HEALTH INC ELAN 2022-06-24 18:45:03 UTC 1.32 0.25 9000000
    ELANCO ANIMAL HEALTH INC ELAN 2022-06-24 18:15:04 UTC 1.32 0.25 9000000
    ELANCO ANIMAL HEALTH INC ELAN 2022-06-24 17:45:03 UTC 1.32 0.25 9000000
    ELANCO ANIMAL HEALTH INC ELAN 2022-06-24 17:15:03 UTC 1.32 0.25 9000000
    ELANCO ANIMAL HEALTH INC ELAN 2022-06-24 16:45:03 UTC 1.3078 0.2622 9000000
    ELANCO ANIMAL HEALTH INC ELAN 2022-06-24 16:15:03 UTC 1.3078 0.2622 9000000
    ELANCO ANIMAL HEALTH INC ELAN 2022-06-24 15:45:03 UTC 1.3078 0.2622 8700000
    ELANCO ANIMAL HEALTH INC ELAN 2022-06-24 15:15:03 UTC 1.3078 0.2622 8700000
    ELANCO ANIMAL HEALTH INC ELAN 2022-06-24 14:45:03 UTC 1.3048 0.2652 8700000
    ELANCO ANIMAL HEALTH INC ELAN 2022-06-24 14:15:03 UTC 1.3048 0.2652 8700000
    ELANCO ANIMAL HEALTH INC ELAN 2022-06-24 13:45:03 UTC 1.3048 0.2652 8700000
    ELANCO ANIMAL HEALTH INC ELAN 2022-06-24 13:15:03 UTC 1.3048 0.2652 8700000
    ELANCO ANIMAL HEALTH INC ELAN 2022-06-24 12:45:03 UTC 1.3048 0.2652 8500000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    Jackson Variable Series Trust- JNL/Nicholas Convertible Arbitrage Fund ELAN -19390.0 shares, $-434142.1 2020-03-31 N-PORT
    FundVantage Trust- Gotham Defensive Long Fund ELAN -93.0 shares, $-2082.27 2020-03-31 N-PORT
    RUSSELL INVESTMENT CO- U.S. Dynamic Equity Fund ELAN -488.0 shares, $-14166.64 2021-01-31 N-PORT
    JNL Series Trust- JNL/AQR Large Cap Relaxed Constraint Equity Fund ELAN -10728.0 shares, $-315939.6 2021-03-31 N-PORT
    Nuveen Investment Trust- Nuveen Equity Market Neutral Fund ELAN -5400.0 shares, $-194292.0 2021-05-31 N-PORT
    SCHWAB CAPITAL TRUST- Schwab Hedged Equity Fund ELAN -4635.0 shares, $-169038.45 2021-07-31 N-PORT
    Steward Funds Inc- Steward Equity Market Neutral Fund ELAN -8000.0 shares, $-208320.0 2022-01-31 N-PORT
    Alger Funds II- Alger Spectra Fund ELAN -426358.0 shares, $-11102362.32 2022-01-31 N-PORT
    Alger Funds II- Alger Dynamic Opportunities Fund ELAN -60065.0 shares, $-1564092.6 2022-01-31 N-PORT
    Principal Funds, Inc- Global Multi-Strategy Fund ELAN 6890.0 shares, $-195744.9 2022-02-28 N-PORT
    Nuveen Investment Trust II- Nuveen Equity Long/Short Fund ELAN -16100.0 shares, $-457401.0 2022-02-28 N-PORT
    FundVantage Trust- Gotham Hedged Plus Fund ELAN -2059.0 shares, $-53719.31 2022-03-31 N-PORT
    Federated Hermes Equity Funds- Federated Hermes Prudent Bear Fund ELAN -9000.0 shares, $-234810.0 2022-03-31 N-PORT
    BlackRock Funds V- BlackRock Strategic Income Opportunities Portfolio ELAN -567000.0 shares, $-608118.84 2022-03-31 N-PORT
    AQR Funds- AQR Alternative Risk Premia Fund ELAN -2338.0 shares, $-60998.42 2022-03-31 N-PORT
    TIFF INVESTMENT PROGRAM- TIFF Multi-Asset Fund ELAN -7214.0 shares, $-188213.26 2022-03-31 N-PORT
    First Trust Exchange-Traded Fund III- First Trust Long/Short Equity ETF ELAN -55747.0 shares, $-1410956.57 2022-04-30 N-PORT

    Elevate your investments